Hanmi Obesity Pipeline
Scope
Date
~
-
Bio & Pharma
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Apr 28, 2025 (Gmt+09:00)
-
Energy
Alaska governor seeks Korean partners for $44 bn LNG project
Alaska Governor Mike Dunleavy arrived in South Korea on Monday to hold a series of one-on-one meetings with top executives from Korean energy and st...
Mar 25, 2025 (Gmt+09:00)
-
Electronics
Hanmi Semiconductor to retire $90 mn treasury shares in May
Hanmi Semiconductor Co. on Thursday announced a plan to retire 130.0 billion won ($90 million) worth of treasury shares in May, marking its largest-...
Feb 13, 2025 (Gmt+09:00)
-
Electronics
Hanmi Semiconductor to build new TC Bonder plant in Incheon
Hanmi Semiconductor Co., South Korea’s leading chip packaging equipment manufacturer, held a ground-breaking ceremony for its seventh plant of...
Jan 07, 2025 (Gmt+09:00)
-
Corporate governance
Hanmi Pharm’s chair poised to win management feud with her son
Hanmi Pharmaceutical Group Chairman Song Young-sook is poised to claim victory in a year-long dispute with her eldest son Lim Jong-yoon to take cont...
Dec 26, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco bags obesity treatment deal worth up to $1.4 bn
SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...
Dec 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Hanmi breaks ground pharmaceuticals complex in Beijing
South Korea's Hanmi Pharmaceutical Co. said on Friday that Beijing Hanmi Pharm, its subsidiary in China, held the groundbreaking ceremony for a proj...
Dec 06, 2024 (Gmt+09:00)
-
Private equity
La Defense might have a say over Hanmi Pharm's family feud
La Defense Partners is expected to exercise a casting vote over the ongoing management dispute at Hanmi Science Co. after the Seoul-based private eq...
Nov 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma to move up launch of anti-obesity drug
South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...
Nov 21, 2024 (Gmt+09:00)
-
Banking & Finance
Hanmi Bank rises from Koreatown lender to regional bank
It began in 1982 as a small community bank for Korean immigrants in Los Angeles, California. Today, Hanmi Bank, under Nasdaq-listed Hanmi Financial ...
Nov 15, 2024 (Gmt+09:00)
-
Investment banking
Junior bankers choosing track records over name value
A number of junior bankers at the Korean offices of major global investment banks such as Morgan Stanely and J.P.Morgan have resigned since July wit...
Aug 30, 2024 (Gmt+09:00)
-
Pension funds
NPS signals more say in Hanmi Pharmaceutical's family feud
South Korea’s National Pension Service is indicating more active involvement in the management of Hanmi Pharmaceutical Group embroiled in a ye...
Aug 20, 2024 (Gmt+09:00)
-
Corporate governance
Korea’s Hanmi family feud to end as key shareholder mediates
South Korean Hanmi Pharmaceutical Group’s founding family is set to conclude an ongoing feud as the group’s top individual shareholder h...
Jul 11, 2024 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor eyes $1.5 billion sales in 2026
Hanmi Semiconductor Co., South Korea’s leading chip packaging equipment manufacturer, has revised upwards its annual sales target for this yea...
Jul 05, 2024 (Gmt+09:00)
-
Korean chipmakers
Booming AI industry boosts chip packaging equipment makers
Global chip packaging equipment manufacturers are enjoying surging demand and skyrocketing share prices thanks to the rapid growth of the artificial...
Jun 24, 2024 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor wins $110 mn HBM equipment order from SK Hynix
South Korean chip equipment company Hanmi Semiconductor Co. announced on Friday that it has received an order from SK Hynix Inc. for its dual TC bon...
Jun 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Handok gets Biocon's obesity drug exclusive distribution in S.Korea
South Korean pharmaceutical company Handok Inc. announced on Friday that it signed an exclusive domestic sales and distribution agreement with India...
May 24, 2024 (Gmt+09:00)
-
Corporate governance
Hanmi to fire founder's wife, entering new round of family feud
South Korea’s Hanmi Pharmaceutical Group is set to enter a new chapter of an ongoing family feud less than two months after the founding famil...
May 13, 2024 (Gmt+09:00)
-
Bio & Pharma
S.Korean anti-obesity drugmakers eye niche demand
The global weight management market has entered a new chapter following the arrival of blockbuster weight-loss medication Wegovy, and South Korean l...
May 07, 2024 (Gmt+09:00)
-
Bio & Pharma
KKR, Hanmi heirs likely to join hands for controlling stake
The two sons of Hanmi Pharmaceutical Group’s founding family, who were approved as board members of the holding firm Hanmi Science Co. at its ...
Apr 02, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Hanmi’s planned merger with OCI scrapped as sons win family feud
Hanmi Pharmaceutical Group’s proposed merger with OCI Holdings Co. has collapsed after two sons of the group’s founding family, who oppo...
Mar 28, 2024 (Gmt+09:00)
-
Corporate governance
Hanmi Science-OCI merger may gain traction with NPS' support
The merger of South Korea’s pharmaceutical holding firm Hanmi Science Co. and chemicals giant OCI Holdings Co. is likely to gain momentum as N...
Mar 27, 2024 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor wins $16 mn HBM equipment order from SK Hynix
South Korean chip equipment company Hanmi Semiconductor Co. announced on Friday that it has secured a 21.5 billion won ($16.1 million) supply deal f...
Mar 22, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Proxy advisor KCGS backs Hanmi founder's sons return to board
South Korea’s top proxy advisory firm has recommended that shareholders of Hanmi Science Co. vote in favor of Hanmi Pharmaceutical Group&rsquo...
Mar 20, 2024 (Gmt+09:00)
-
Bio & Pharma
Vivid Health gets seed round from Kakao Ventures
Vivid Health, a South Korean startup that operates an obesity treatment management platform announced on Wednesday that it got a seed round investme...
Mar 06, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
OCI-Hanmi merger faces tougher hurdles amid family feud
Hanmi Pharmaceutical Group’s aim to merge with chemicals giant OCI Group is hitting some roadblocks amid a prolonged feud between the family o...
Feb 13, 2024 (Gmt+09:00)
-
Korean Investors
Samsung Asset to launch S.Korea's first obesity treatment ETF
Korea Exchange announced on Thursday that it will list Samsung Asset Management's "KODEX Global Obesity Treatment Top 2 Plus exchange-traded fund (E...
Feb 08, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
Jan 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets Chinese patent for obesity treatment strain
South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strai...
Jan 17, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman
Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...
Jan 15, 2024 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand